已收盤 02-06 16:00:00 美东时间
+0.300
+5.04%
今日重点评级关注:花旗:维持Caribou Biosciences"买入"评级,目标价从5美元升至8美元;HC Wainwright & Co.:上调MoonLake Immunotherapeutics - Class A Ordinary Shares评级至"买入",目标价30美元
2025-11-04 10:31
今日重点评级关注:康托·菲茨杰拉德:维持Cabaletta Bio"超配"评级,目标价从15美元升至30美元;HC Wainwright & Co.:维持Invivyd"买入"评级,目标价从5美元升至10美元
2025-11-03 20:20
Stifel analyst Parker Lane maintains Weave Communications (NYSE:WEAV) with a Buy and lowers the price target from $13 to $11.
2025-10-31 22:50
Weave Communications shares are trading higher after the company reported bette...
2025-10-31 04:47
今日重点评级关注:花旗:维持Apellis Pharmaceuticals"买入"评级,目标价从46美元升至52美元;BTIG:维持Strategy"买入"评级,目标价从620美元升至700美元
2025-08-04 09:30
Stifel analyst Parker Lane maintains Weave Communications (NYSE:WEAV) with a Buy and lowers the price target from $16 to $13.
2025-08-02 00:18
Gainers Weave Communications (NYSE:WEAV) shares increased by 14.1% to $8.33 du...
2025-08-01 05:06
Weave Communications shares are trading higher after the company reported bette...
2025-08-01 04:59
Weave Communications (NYSE:WEAV) affirms FY2025 sales outlook from $236.800 million-$239.800 million to $236.800 million-$239.800 million vs $237.745 million estimate.
2025-08-01 04:14
Weave Communications (NYSE:WEAV) reported quarterly earnings of $0.02 per share which beat the analyst consensus estimate of $0.00 by 1900 percent. The company reported quarterly sales of $58.470 million which beat the
2025-08-01 04:03